Basic Information
Basic information for LINC00343-220-17aa
Peptide Name LINC00343-220-17aa
Genome Position chr13:105731580-105731630[+]
Species Human
Peptide Sequence MRPSAKKIKKFVQSNFL
Peptide Length 17
Unique No (LINC00343-201-17aa,LINC00343-204-17aa,LINC00343-206-17aa,LINC00343-209-17aa,LINC00343-210-17aa,LINC00343-211-17aa,LINC00343-212-17aa,LINC00343-213-17aa,LINC00343-214-17aa,LINC00343-215-17aa,LINC00343-217-17aa,LINC00343-218-17aa,LINC00343-219-17aa,LINC00343-221-17aa,LINC00343-223-17aa,LINC00343-224-17aa,LINC00343-226-17aa,LINC00343-228-17aa,LINC00343-229-17aa,LINC00343-231-17aa,LINC00343-234-17aa,LINC00343-235-17aa,LINC00343-236-17aa,LINC00343-238-17aa,LINC00343-242-17aa,LINC00343-245-17aa,LINC00343-247-17aa,LINC00343-249-17aa,LINC00343-251-17aa,LINC00343-254-17aa,LINC00343-256-17aa,LINC00343-259-17aa,LINC00343-260-17aa,LINC00343-261-17aa-1,LINC00343-266-17aa-1,LINC00343-269-17aa,LINC00343-272-17aa,LINC00343-274-17aa,LINC00343-276-17aa,LINC00343-278-17aa,LINC00343-279-17aa,LINC00343-280-17aa,LINC00343-282-17aa-2,LINC00343-283-17aa,LINC00343-285-17aa,LINC00343-286-17aa-2,LINC00343-287-17aa,LINC00343-295-17aa,LINC00343-300-17aa,LINC00343-301-17aa,LINC00343-304-17aa,LINC00343-305-17aa,LINC00343-308-17aa,LINC00343-311-17aa,LINC00343-312-17aa,LINC00343-313-17aa,LINC00343-316-17aa,LINC00343-319-17aa,LINC00343-322-17aa,LINC00343-323-17aa,LINC00343-327-17aa,LINC00343-329-17aa,LINC00343-330-17aa,LINC00343-331-17aa)
Grand Average of Hydropathicity -0.5
Relative Molecular Mass 2310.71
Experimental Evidences no
lncRNA ID/Name ENSG00000226620;LINC00343
Transcript ID/Name ENST00000654904;LINC00343-220
Transcript Length 1308
Coding Ability 0.5642
DNA Sequence Corresponding to Peptide ATGAGACCATCAGCAAAGAAGATAAAGAAGTTTGTACAAAGCAACTTTTTA
Experimental Evidences
Conservation
   Conservation
Peptide-MHC I binding
   Peptide-MHC I binding
Peptide-MHC II binding
   Peptide-MHC II binding
Spatial Expression
   Spatial Expression
Source :   
Clinical Relevance
   Clinical Relevance
Source :   
Cancer :